Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.
暂无分享,去创建一个
M. Varella‐Garcia | G. Noon | S. Erzurum | P. Thistlethwaite | S. Comhair | R. Tuder | M. Geraci | C. Coldren | M. Aldred | K. Asosingh | Weiling Xu | M. Varella-Garcia
[1] G. Noon,et al. Acquired Genetic Abnormalities in the Lungs of Patients with Pulmonary Arterial Hypertension. , 2009, ATS 2009.
[2] R. Matsuoka,et al. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension , 2009, Journal of Medical Genetics.
[3] C. Cantor,et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.
[4] M. Skokan,et al. Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[5] H. C. Fan,et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.
[6] M. Humbert,et al. Severe pulmonary arterial hypertension: a forme fruste of cancer? , 2008, American journal of respiratory and critical care medicine.
[7] N. Voelkel,et al. The cancer paradigm of severe pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.
[8] R. Dweik,et al. High levels of hyaluronan in idiopathic pulmonary arterial hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[9] J. K. Kundu,et al. Inflammation: gearing the journey to cancer. , 2008, Mutation research.
[10] D. Hommes,et al. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. , 2008, Gastroenterology.
[11] Richard P. Hill,et al. Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.
[12] B. Gómez-González,et al. Genome instability: a mechanistic view of its causes and consequences , 2008, Nature Reviews Genetics.
[13] S. Erzurum,et al. Copyright © American Society for Investigative Pathology DOI: 10.2353/ajpath.2008.070705 Cardiovascular, Pulmonary and Renal Pathology Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension , 2022 .
[14] M. Maitland,et al. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. , 2008, American journal of physiology. Heart and circulatory physiology.
[15] Z. Talebizadeh,et al. Comparison of X-chromosome inactivation patterns in multiple tissues from human females , 2007, Journal of Medical Genetics.
[16] Y. Miller,et al. Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer. , 2007, American journal of respiratory and critical care medicine.
[17] S. Erzurum,et al. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[18] C. Selmi,et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis , 2007, Hepatology.
[19] Kurt R Stenmark,et al. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[20] Raed A Dweik,et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.
[21] J. Cogan,et al. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. , 2006, American journal of respiratory and critical care medicine.
[22] H. Willard,et al. X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. , 2006, American journal of human genetics.
[23] S. Archer,et al. An Abnormal Mitochondrial–Hypoxia Inducible Factor-1&agr;–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats: Similarities to Human Pulmonary Arterial Hypertension , 2006, Circulation.
[24] M. Humbert,et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension , 2006, Human mutation.
[25] G. Semenza. Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology. , 2005, Chest.
[26] C. Selmi,et al. X Chromosome Monosomy: A Common Mechanism for Autoimmune Diseases1 , 2005, The Journal of Immunology.
[27] L. Huang,et al. Genetic Instability: The Dark Side of THE Hypoxic Response , 2005, Cell cycle.
[28] R. Trembath,et al. Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension , 2005, Circulation.
[29] Dhara N. Amin,et al. Tumor-Associated Endothelial Cells with Cytogenetic Abnormalities , 2004, Cancer Research.
[30] C. Borg,et al. X-Chromosome Genetics and Human Cancer , 2004, Nature Reviews Cancer.
[31] R. Trembath,et al. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor , 2002, Circulation.
[32] G. Semenza,et al. Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.
[33] W F Bodmer,et al. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. , 2001, American journal of human genetics.
[34] N. Voelkel,et al. Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension , 2001, Circulation research.
[35] S. Erzurum,et al. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] K. Shroyer,et al. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.
[37] K. Shroyer,et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.
[38] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[39] P. N. Rao,et al. Monosomy X as a recurring sole cytogenetic abnormality associated with myelodysplastic diseases. , 1997, Cancer genetics and cytogenetics.
[40] B. Groves,et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.
[41] D. Buff. Primary pulmonary hypertension. , 1987, Annals of internal medicine.
[42] M. Yacoub,et al. The pathology of the early and late stages of primary pulmonary hypertension. , 1987, British heart journal.
[43] S. Moncada,et al. Prostaglandins in the pathogenesis and prevention of vascular disease. , 1987, Blood reviews.